Topic: Novartis AG
ZURICH (Reuters) - Novartis' Sandoz unit has agreed to pay $150 million Swiss francs to settle claims it charged the U.S. and state governments inflated prices for drugs, a Swiss newspaper reported on Sunday.Under the deal Novartis will pay the U.S. government ...
ZURICH (Reuters) - Novartis' Ilaris helps patients with the most serious form of childhood arthritis, a second late-stage study has shown, further boosting prospects for the Swiss drugmaker's medicine that hit a setback earlier this year.Ilaris, or ACZ885, met both of its ...
Swiss pharmaceutical giant Novartis said on Tuesday it would slash 2,000 jobs, mostly in Switzerland and the United States, despite reporting third quarter net profits of $3.53 billion (2.5 billion euros).The firm said in a statement that profits for the quarter were ...
ZURICH (Reuters) - Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday.The Basel-based group has already ...
AMSTERDAM (Reuters) - Swiss drugmaker Novartis said it has applied to start selling its experimental drug to treat smoker's cough -- which afflicts 80 million people worldwide -- after tests showed that it helped patients breathe more easily.Novartis has carried out late-stage ...
ZURICH (Reuters) - Swiss drugmaker Novartis cut 2,500 jobs at sites across the world in a bid to control costs, the daily Tages Anzeiger reported on Saturday.Like many pharmaceutical companies, Novartis is starting to face generic competition, with its breast cancer drug ...
(Reuters) - Patients with the most serious form of childhood arthritis can get substantial symptom relief from a Novartis drug, researchers said on Friday, raising hopes for a product that had a recent setback in its application to treat gout.Ilaris, or ACZ885, ...
Swiss pharmaceutical giant Novartis said on Tuesday its second-quarter net profit rose 12 percent to $2.72 billion (1.9 billion euros), lifted by strong demand for new drugs."Our recently launched products continue to transform our portfolio, our new products grew 46 percent and ...
MOSCOW (Reuters) - Russian police searched the offices of four pharmaceutical companies in Moscow on Tuesday, including Swiss drug maker Novartis AG and Israel-based Teva, the business daily Vedomosti reported, quoting a police source.Vedomosti, in a report on its website, quoted the ...
ZURICH (Reuters) - El laboratorio suizo Novartis AG dijo el miércoles que un nuevo estudio muestra que su fármaco oftálmico Lucentis es más seguro que el medicamento oncológico Avastin para el tratamiento de la degeneración macular. Novartis indicó que el análisis realizado ...
Photo Gallery
-
Novartis Settlement
U.S. Attorney Zane David Memeger smiles after speaking during a news ...AP News - -
Novartis results
Daniel Vasella, Chief Executive Officer of Swiss pharmaceutical group Novartis, is projected ...ZUMA Press Inc - -
Novartis press conference
epa01616452 Daniel Vasella, CEO Novartis, center, speaks to the media, while Joerg ...ZUMA Press Inc -
From Around the Web
Video Gallery
-
Novartis AG - Annual Press Conference 2011 ...
All Footage-Video -- important speeches, Q&A - from the Annual Press ...2011-01-27 -
News Update: Novartis AG Agrees to ...
"Officials from Novartis AG (NYSE:NVS) announced Thursday that the ...2010-09-30 -
Healthcare - where are we headed?
Patients, diseases and healthcare are changing - and this affects your ...2010-04-12
